Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
Study Number: 

I 240813

Phase: 
Early Phase
Trial categories: 
Lymphoma
Immunotherapy
Early Phase Clinical Trial
Antibody therapy
Principal Investigator: